Key Insights

Highlights

Success Rate

25% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 65/100

Termination Rate

75.0%

3 terminated out of 4 trials

Success Rate

25.0%

-61.5% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results25% success

Data Visualizations

Phase Distribution

2Total
P 2 (1)
P 3 (1)

Trial Status

Terminated3
Completed1

Trial Success Rate

25.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (4)

Research Network

Activity Timeline